- Colonic necrosis in a young patient receiving oral kayexalate in sorbitol: case report and literature review.
Colonic necrosis in a young patient receiving oral kayexalate in sorbitol: case report and literature review.
The Kaohsiung journal of medical sciences (2011-04-06)
Yueh-Hung Chou, Hsin-Yi Wang, Min-Shu Hsieh
PMID21463839
ZUSAMMENFASSUNG
Kayexalate (sodium polystyrene sulfonate) is a cation-exchange resin used to treat patients with hyperkalemia. Concomitant administration of kayexalate and sorbitol may induce gastrointestinal injury, which is potentially lethal. However, this well-documented complication is often underrecognized both clinically and pathologically. We propose a typical case along with colonoscopic photos and microscopic pictures. Additionally, we also present a review of the literature on this rare drug-induced side effect.
MATERIALIEN
Produktnummer
Marke
Produktbeschreibung
Sigma-Aldrich
D-Sorbit, ≥98% (GC), BioReagent, suitable for cell culture, suitable for plant cell culture
Sigma-Aldrich
Sorbit F -Lösung, 70 wt. % in H2O, Contains mainly D-sorbitol with lesser amounts of other hydrogenated oligosaccharides
Sorbit, European Pharmacopoeia (EP) Reference Standard